# Findings on Impact of Circadian Genes and Bipolar Disorder: A Bibliometric Analysis From 1996 to 2024

**Authors:** Zhuoer Ruan, Jie Zhu

PMC · DOI: 10.1002/brb3.71274 · Brain and Behavior · 2026-02-16

## TL;DR

This study maps global research trends on circadian genes and bipolar disorder from 1996 to 2024, showing rising interest and key research areas like depression, light therapy, and sleep.

## Contribution

A comprehensive bibliometric analysis of global research trends and hotspots in circadian genes and bipolar disorder from 1996 to 2024.

## Key findings

- The number of publications on circadian genes and bipolar disorder has grown at a 9.88% annual rate.
- Research hotspots include depression, light therapy, lithium treatment, and genetic associations.
- Emerging trends focus on sleep patterns, brain functions, and risk factors in bipolar disorder.

## Abstract

The disturbances of circadian genes are implicated in the pathophysiology of bipolar disorder (BD). This bibliometric analysis aims to explore global trends and hotspots in research on circadian genes and BD.

A bibliometric analysis.

A systematic search was carried out on the Web of Science Core Collection (WoSCC) database to collect publications regarding circadian genes and BD. Subsequently, bibliometric analysis and visualization utilized VOSviewer (V 1.6.20), CiteSpace (V 6.3.R1), and the R package “Bibliometrix” (V 4.3.3).

The 400 articles involved 2405 authors from 1649 institutions, citing 18,840 sources in 166 journals. The number of publications has been consistently rising, with a 9.88% annual growth rate. The USA, Italy, and China dominated with the most articles. The most cited articles focused on the genetics of circadian disorders. The top institutions were the University of California system, the University of California, San Diego, and Université Paris. High‐impact authors included McClung Colleen A., McCarthy Michael J., and Benedetti Francesco. The top journals by H‐index were Chronobiology International, Journal of Affective Disorders, and American Journal of Medical Genetics. The keyword co‐occurrence analysis revealed focus on “depression,” “neurons,” “light therapy,” “genome wide association,” and “lithium.” The burst keywords highlighted the latest trends, including “sleep” and “brain,” with consistent emphasis on “risk.”

This bibliometric analysis provides insights into the global trends and hotspots of research on circadian genes and BD. The hotspots are on symptoms, genetic associations, and treatment in BD, with frontiers exploring sleep patterns, brain functions, and risk factors.

This study maps global research trends on circadian genes and bipolar disorder from 1996 to 2024 using bibliometric methods. Analysis of 400 articles reveals a steady growth in publications, with the USA, Italy, and China as leading contributors. Key research hotspots include depression, neuronal mechanisms, light therapy, genetic associations, and lithium treatment, with emerging focus on sleep, brain function, and risk factors. Major clusters represent clinical symptoms, molecular mechanisms, therapeutic strategies, genetic studies, and animal models. Findings provide insights for future research and clinical practice in psychiatric genetics.

## Linked entities

- **Diseases:** bipolar disorder (MONDO:0004985), depression (MONDO:0002050)

## Full-text entities

- **Genes:** VIP (vasoactive intestinal peptide) [NCBI Gene 7432] {aka PHM27}, NR1D2 (nuclear receptor subfamily 1 group D member 2) [NCBI Gene 9975] {aka BD73, EAR-1R, REVERBB, REVERBbeta, RVR}, PER1 (period circadian regulator 1) [NCBI Gene 5187] {aka PER, RIGUI, hPER}, BMAL2 (basic helix-loop-helix ARNT like 2) [NCBI Gene 56938] {aka ARNTL2, CLIF, MOP9, PASD9, bHLHe6}, RORC (RAR related orphan receptor C) [NCBI Gene 6097] {aka IMD42, NR1F3, RORG, RZR-GAMMA, RZRG, TOR}, CSNK1D (casein kinase 1 delta) [NCBI Gene 1453] {aka ASPS, CKI-delta, CKId, CKIdelta, FASPS2, HCKID}, CLOCK (clock circadian regulator) [NCBI Gene 9575] {aka KAT13D, bHLHe8}, Per2 (period circadian clock 2) [NCBI Gene 18627] {aka mKIAA0347, mPer2}, CSNK1E (casein kinase 1 epsilon) [NCBI Gene 1454] {aka CKIe, CKIepsilon, HCKIE}, Per3 (period circadian clock 3) [NCBI Gene 18628] {aka 2810049O06Rik, mPer3}, Rora (RAR-related orphan receptor alpha) [NCBI Gene 19883] {aka 9530021D13Rik, Nr1f1, ROR1, ROR2, ROR3, nmf267}, NPAS2 (neuronal PAS domain protein 2) [NCBI Gene 4862] {aka MOP4, PASD4, bHLHe9}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], RORA (RAR related orphan receptor A) [NCBI Gene 6095] {aka IDDECA, NR1F1, ROR1, ROR2, ROR3, RORa1}, CRY2 (cryptochrome circadian regulator 2) [NCBI Gene 1408] {aka HCRY2, PHLL2}, CRY1 (cryptochrome circadian regulator 1) [NCBI Gene 1407] {aka DSPD, PHLL1}, Nr1d1 (nuclear receptor subfamily 1, group D, member 1) [NCBI Gene 217166] {aka A530070C09Rik}, CAMK2A (calcium/calmodulin dependent protein kinase II alpha) [NCBI Gene 815] {aka CAMKA, CaMKIINalpha, CaMKIIalpha, MRD53, MRT63}, TIMELESS (timeless circadian regulator) [NCBI Gene 8914] {aka FASPS4, TIM, TIM1, hTIM}, RORB (RAR related orphan receptor B) [NCBI Gene 6096] {aka EIG15, NR1F2, ROR-BETA, RORbeta, RZR-BETA, RZRB}, PER3 (period circadian regulator 3) [NCBI Gene 8863] {aka FASPS3, GIG13}, Per1 (period circadian clock 1) [NCBI Gene 18626] {aka Hftm, Per, m-rigui, mPer1}, BMAL1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 406] {aka ARNTL, ARNTL1, BMAL1c, JAP3, MOP3, PASD3}, VIPR2 (vasoactive intestinal peptide receptor 2) [NCBI Gene 7434] {aka C16DUPq36.3, DUP7q36.3, PACAP-R-3, PACAP-R3, VIP-R-2, VPAC2}, NR1D1 (nuclear receptor subfamily 1 group D member 1) [NCBI Gene 9572] {aka EAR1, REVERBA, REVERBalpha, THRA1, THRAL, ear-1}, PER2 (period circadian regulator 2) [NCBI Gene 8864] {aka FASPS, FASPS1}, MT1IP (metallothionein 1I, pseudogene) [NCBI Gene 644314] {aka MT1, MT1I, MTE}
- **Diseases:** Affective (MESH:D019964), Seasonal affective disorder (MESH:D016574), biphasic disorder (MESH:D009358), circadian disorders (MESH:D021081), sleep disturbances (MESH:D012893), insomnia (MESH:D007319), psychiatric (MESH:D001523), BD (MESH:D001714), sleep deprivation (MESH:D012892), depression (MESH:D003866), hypomania (MESH:D000087122), bipolar affective disorder (MESH:C564108)
- **Chemicals:** Lithium (MESH:D008094), glutamate (MESH:D018698), serotonin (MESH:D012701), dopamine (MESH:D004298), Melatonin (MESH:D008550)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12910130/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12910130/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12910130/full.md

---
Source: https://tomesphere.com/paper/PMC12910130